Cover Image
市場調查報告書

皰疹感染症:全球臨床實驗檢討

Herpes Infections Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 320838
出版日期 內容資訊 英文 128 Pages
訂單完成後即時交付
價格
Back to Top
皰疹感染症:全球臨床實驗檢討 Herpes Infections Global Clinical Trials Review, H2, 2014
出版日期: 2014年11月30日 內容資訊: 英文 128 Pages
簡介

本報告提供皰疹感染症的臨床試驗相關之基本資料及數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,臨床試驗的主要製藥企業及研究機關簡介等資料。

簡介

  • 皰疹感染症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的主要5個國家的臨床實驗數量
    • 歐洲的主要5個國家的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中東·非洲的主要5個國家臨床實驗數量
    • 中南美的主要5個國家臨床實驗數量

G7各國臨床實驗數量:感染症臨床實驗上皰疹感染症所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:感染症臨床實驗上皰疹感染症所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗上目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

皰疹感染症治療藥臨床實驗的主要參與企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • GlaxoSmithKline plc
    • Merck & Co., Inc.
    • F. Hoffmann-La Roche Ltd.
    • Novartis AG
    • Astellas Pharma Inc.
    • Sanofi
    • Pfizer Inc.
    • AstraZeneca PLC
    • Vical Incorporated
    • Gilead Sciences, Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • The National Institute of Allergy and Infectious Diseases
    • National Cancer Institute
    • University of Washington
    • National Heart, Lung, and Blood Institute
    • National Center for Research Resources
    • National Eye Institute
    • Baylor College of Medicine
    • University of California, San Francisco
    • University of Alabama at Birmingham
    • Memorial Sloan Kettering Cancer Center

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2452CTIDB

GlobalData's clinical trial report, "Herpes Infections Global Clinical Trials Review, H2, 2014" provides data on the Herpes Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Herpes Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Herpes Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Herpes Infections
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Herpes Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Herpes Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Herpes Infections
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Herpes Infections Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Herpes Infections
  • Oct 08, 2014: NanoBio To Present Data Demonstrating The Potential For Its Intranasal Vaccine To Protect Against Genital Herpes Infection
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Astellas Pharma Inc.
      • Clinical Trial Overview of Astellas Pharma Inc.
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Vical Incorporated
      • Clinical Trial Overview of Vical Incorporated
      • Gilead Sciences, Inc.
      • Clinical Trial Overview of Gilead Sciences, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • University of Washington
      • Clinical Trial Overview of University of Washington
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • National Center for Research Resources
      • Clinical Trial Overview of National Center for Research Resources
      • National Eye Institute
      • Clinical Trial Overview of National Eye Institute
      • Baylor College of Medicine
      • Clinical Trial Overview of Baylor College of Medicine
      • University of California, San Francisco
      • Clinical Trial Overview of University of California, San Francisco
      • University of Alabama at Birmingham
      • Clinical Trial Overview of University of Alabama at Birmingham
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Herpes Infections Therapeutics, Global, Clinical Trials by Region, 2014*
  • Herpes Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Herpes Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Herpes Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Herpes Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Herpes Infections Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Herpes Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Herpes Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Herpes Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Herpes Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Herpes Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Herpes Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Herpes Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Herpes Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Herpes Infections Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Herpes Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Herpes Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Herpes Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Herpes Infections Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Herpes Infections Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Herpes Infections Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Herpes Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Herpes Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Herpes Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Herpes Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Herpes Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014*
  • Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Vical Incorporated, 2014*
  • Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014*
  • Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014*
  • Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*
  • Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014*
  • Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2014*
  • Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2014*
  • Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014*
  • Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2014*
  • Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*

List of Figures

  • Herpes Infections Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Herpes Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Herpes Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Herpes Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Herpes Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Herpes Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Herpes Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Herpes Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Herpes Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Herpes Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Herpes Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Herpes Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Herpes Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Herpes Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Herpes Infections Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Herpes Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Herpes Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Herpes Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Herpes Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Herpes Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Herpes Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Herpes Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Herpes Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top